van houten ma

van houten ma


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2024 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
LLLisanne M. van Leeuwen
Lisanne M. van Leeuwen
EFElandri Fourie
Elandri Fourie
GBGerrie van Den Brink
Gerrie van Den Brink
VBVincent Bekker
Vincent Bekker
VMvan houten ma
van houten ma

30 November 2024 in Vaccine
Verified
Journal Article
Closed access
LHLisette M. Harteveld
Lisette M. Harteveld
LLLisanne M. van Leeuwen
Lisanne M. van Leeuwen
SESjoerd M. Euser
Sjoerd M. Euser
LSLucy J. Smit
Lucy J. Smit
KVKarlijn C. Vollebregt
Karlijn C. Vollebregt
VMvan houten ma
van houten ma

9 May 2025 in Journal of Infection
Verified
Journal Article
Open access
MHMarieke L.A. de Hoog
Marieke L.A. de Hoog
EWEmma S.E.M. Hauser - van Westrhenen
Emma S.E.M. Hauser - van Westrhenen
AWAngelique M.A.M. Winkel
Angelique M.A.M. Winkel
MJMenno D. de Jong
Menno D. de Jong
VMvan houten ma
van houten ma
PBPatricia C.J.L. Bruijning-Verhagen
Patricia C.J.L. Bruijning-Verhagen
This individual patient data meta-analysis investigates the impact of SARS-CoV-2 infection with or without other respiratory viruses on Acute Respiratory Illness (ARI) occurrence and severity. We pooled individual participant data from 11 prospective COVID-19 community and healthcare cohorts (2020-2024). A subject's first respiratory sample was tested for SARS-CoV-2 and a panel of respiratory viruses. The association of SARS-CoV-2 single versus viral co-infection with ARI occurrence and severity was analyzed using mixed effects regression. The analysis was repeated for Human Rhinovirus (HRV). Of 1606 SARS-CoV-2 positive episodes (1597 subjects), 124 (7.7%) were co-infected with another respiratory virus, the majority with HRV (66.1%). SARS-CoV-2 Co-infection was associated with a lower odds of ARI than SARS-CoV-2 single infection in community cohorts (adjusted (a) OR: 0.39; 95%CI: 0.21-0.71). This association was not observed for ARI severity in healthcare cohorts (aOR: 1.76; 95%CI: 0.67-4.61). Co-infection versus single infection with HRV was associated with higher ARI occurrence and severity in both settings (community: aOR: 1.72 and healthcare: aOR: 6.04). In community settings, SARS-CoV-2 co-infection with another virus, particularly HRV, attenuates ARI compared to SARS-CoV-2 single infection. The low number of detected co-infections with other viruses, such as influenza or RSV, limits generalizability to other combinations of co-infecting viruses.

Verified
Journal Article
Open access
PDF file
MGMarco Goeijenbier
Marco Goeijenbier
SBSjoerd van der Bie
Sjoerd van der Bie
DSDennis Souverein
Dennis Souverein
DBD. Bolluyt
D. Bolluyt
MNM. Nagel
M. Nagel
SLSteven van Lelyveld
Steven van Lelyveld
Background: Mycoplasma pneumoniae (M. pneumoniae) infections can progress to severe respiratory complications, necessitating intensive care treatment. Recent post COVID-19 pandemic surges underscore the need for timely diagnosis, given potential diagnostic method limitations. Methods: A retrospective case series analysis was conducted on M. pneumonia PCR-positive patients admitted to two Dutch secondary hospitals’ ICUs between January 2023 and February 2024. Clinical presentations, treatments, outcomes, and mechanical ventilation data were assessed. Results: Seventeen ICU-admitted patients were identified, with a median age of 44 years, primarily due to hypoxia. Non-invasive ventilation was effective for most, while five required invasive mechanical ventilation. None of the patients required extracorporeal membrane oxygenation. No fatalities occurred. Post-PCR, treatment was adjusted to doxycycline or azithromycin; seven received steroid treatment. Discussion: Increased ICU admissions for M. pneumoniae infection were observed. Diverse clinical and radiological findings emphasize heightened clinical awareness. Early molecular diagnostics and tailored antibiotic regimens are crucial since beta-lactam antibiotics are ineffective. Conclusion: This study highlights the escalating challenge of severe M. pneumoniae infections in ICUs, necessitating a multifaceted approach involving accurate diagnostics, vigilant monitoring, and adaptable treatment strategies for optimal patient outcomes.

15 January 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SBSjoerd van der Bie
Sjoerd van der Bie
MHMark E. Haaksma
Mark E. Haaksma
BVBen Vermin
Ben Vermin
HAHidde van Assema
Hidde van Assema
EGEric C.M. van Gorp
Eric C.M. van Gorp
MGMarco Goeijenbier
Marco Goeijenbier
Background: Chronic obstructive pulmonary disease (COPD) is a major health concern. Acute exacerbations (AECOPD) may require intensive care unit (ICU) admission and mechanical ventilation. Acute infections and chronic colonization of the respiratory system are known to precipitate AECOPD. Detailed knowledge of the respiratory microbiome could lead to effective treatment and prevention of exacerbations. Objective: The aim of this review is to summarize the available evidence on the respiratory microbiome of patients with a severe AECOPD requiring mechanical ventilation and intensive care admission. Methods: A systematic literature search was conducted to identify the published papers until January 2023. The collected data were then subjected to qualitative analysis. After the first analysis, a secondary focused review of the most recent publications studying the relationship between microbiome and mortality in AECOPD was performed. Results: Out of 120 screened articles six articles were included in this review. Potentially pathogenic microorganisms (PPMs) were identified in 30% to 72% of the patients with community-acquired bacteria, gram-negative enteric bacilli, Stenotrophomonas and Pseudomonas being the most frequently isolated. During hospitalization, 21% of patients experienced colonization by PPMs. Adequate antimicrobial therapy resulted in the eradication of 77% of the identified PPMs. However, 24% of the bacteria displayed multi-drug resistance leading to prolonged or failure of eradication. Conclusion: PPMs are prevalent in a significant proportion of patients experiencing an AECOPD. The most identified PPMs include community-acquired pathogens and gram-negative enteric bacilli. Notably, no differences in mortality or duration of ventilation were observed between patients with and without isolated PPMs. However, the included studies did not investigate the virome of the patients, which may influence the microbiome and the outcome of infection. Therefore, further research is essential to comprehensively investigate the complete microbial and viral composition of the lower respiratory system in COPD patients admitted to the ICU.

29 June 2024 in Journal of Infection
Verified
Journal Article
Open access
TBTrisja T. Boom
Trisja T. Boom
MHMarieke L.A. de Hoog
Marieke L.A. de Hoog
IWIlse Westerhof
Ilse Westerhof
VJVincent W.V. Jaddoe
Vincent W.V. Jaddoe
VHValerie D. Heuvelman
Valerie D. Heuvelman
PBPatricia C.J.L. Bruijning-Verhagen
Patricia C.J.L. Bruijning-Verhagen
Children are generally considered main drivers of transmission for respiratory viruses, but the emergence of SARS-CoV-2 challenged this paradigm. Human rhinovirus (RV) continued to co-circulate throughout the pandemic, allowing for direct comparison of age-specific infectivity and susceptibility within households between these viruses during a time of low SARS-CoV-2 population immunity. Households with children were prospectively monitored for ≥23 weeks between August 2020 and July 2021. Upon onset of respiratory symptoms in a household, an outbreak study was initiated, including questionnaires and repeated nasal self-sampling in all household members. Swabs were tested by PCR. Age-stratified within-household secondary attack rates (SARs) were compared between SARS-CoV-2 and RV. A total of 307 households participated, including 582 children and 627 adults. Overall, SAR was lower for SARS-CoV-2 than for RV (aOR 0.55) and age distributions differed between both viruses (p < 0.001). Following household exposure, children were significantly less likely to become infected with SARS-CoV-2 compared to RV (aOR 0.16), whereas this was opposite in adults (aOR 1.71). In households, age-specific susceptibility to SARS-CoV-2 and RV differs and drives differences in household transmission between these pathogens. This highlights the importance of characterizing age-specific transmission risks, particularly for emerging infections, to guide appropriate infection control interventions.